Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Abbott Laboratories (ABT) had Revenue of $40.11B for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$40.11B
Net Income	$5.72B
Cost of Goods Sold	$17.98B
Gross Profit	$22.13B
Operating Expenses	$33.63B
Operating Income	$6.48B
Non-Operating Income/Expense	$186.00M
Pre-Tax Income	$6.66B
Normalized Pre-Tax Income	$6.66B
Income after Taxes	$5.72B
Income from Continuous Operations	$5.72B
Consolidated Net Income/Loss	$5.72B
Normalized Income after Taxes	$5.72B
EBIT	$6.48B
EBITDA	$9.72B
Weighted-Average Shares Outstanding (Basic)	1.74B
Weighted-Average Shares Outstanding (Diluted)	1.75B
Earnings per Share (EPS) (Basic)	$3.28
Earnings per Share (EPS) (Diluted)	$3.26
Balance Sheet Financials
Current Assets	$22.67B
Property, Plant, and Equipment	$10.15B
Long-Term Assets	$50.54B
Total Assets	$73.21B
Current Liabilities	$13.84B
Long-Term Debt	$13.60B
Long-Term Liabilities	$20.55B
Total Liabilities	$34.39B
Common Equity	$38.83B
Tangible Shareholders Equity	$6.33B
Shareholders Equity	$38.83B
Common Shares Outstanding	1.73B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$7.26B
Cash Flow from Investing Activities	$-3.13B
Cash Flow from Financial Activities	$-7.09B
Beginning Cash	$9.88B
End Cash	$6.90B
Increase/Decrease in Cash	$-2.99B
Stock-Based Compensation	$644.00M
Common Stock Dividends Paid	$-3.56B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.64
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.26
Debt to Equity Ratio	0.38
Gross Margin	55.18%
Operating Margin	16.15%
EBIT Margin	16.15%
EBITDA Margin	24.24%
Pre-Tax Profit Margin	16.61%
Profit Margin	14.27%
Free Cash Flow	$5.06B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.55
Inventory Turnover	2.74
Receiveable Turnover	6.11
Days Sales in Receivables	59.74
Return on Equity	14.74%
Return on Tangible Equity	90.37%
Return on Assets	7.82%
Return on Investments	10.92%
Book Value Per Share	$22.39
Free Cash Flow per Share	$2.89
Operating Cash Flow per Share	$4.15

Data from Zacks Investment Research, Inc.